Nefrogard Tablet: Uses, Benefits, and Kidney Support
Written by Dr. Zack Ferris in TheSkyMeds Editorial Standards
Medically reviewed by Jonathan Reed, Medical Content Reviewer Sept 23 2026
Nefrogard Tablet is an alpha-ketoanalogue preparation used as part of nutritional management for selected people with chronic kidney disease (CKD), particularly when a clinician has prescribed protein restriction. Current Indian product information identifies Nefrogard Tablet as containing alpha-ketoanalogues and essential amino acids designed to support protein nutrition while limiting additional nitrogenous waste. This approach is different from taking an ordinary vitamin or general kidney supplement. International CKD guidance recognizes a role for ketoacid analogue-supplemented very-low-protein diets in carefully selected, metabolically stable adults at risk of kidney failure, but only under close supervision. Nefrogard does not repair damaged kidneys or cure CKD, and its potential benefit depends heavily on the accompanying diet and overall kidney treatment plan. This guide explains its uses, mechanism, potential benefits, limitations, safety considerations, and the evidence behind ketoanalogue-based kidney support.
What Is Nefrogard Tablet and What Is It Used For?
Nefrogard is a prescription nutritional therapy intended for chronic kidney disease rather than a general wellness supplement. Centaur Pharmaceuticals' prescribing information describes its indication as prevention and therapy of kidney damage in CKD alongside a protein-restricted diet.
Current Indian pharmacy information similarly lists Nefrogard as an alpha-ketoanalogue preparation used in CKD.
The Centaur Pharmaceuticals Nefrogard prescribing information identifies ketoanalogues of essential amino acids plus amino acids in the formulation and specifically places the product within protein-restricted CKD management.
Is Nefrogard a kidney medicine or a nutritional supplement?
It is best understood as specialized nutritional therapy used within medical CKD management.
Ketoanalogues are related to essential amino acids but lack the nitrogen-containing amino group. Once inside the body, they can accept nitrogen and be converted into corresponding amino acids, helping provide substrates for protein synthesis without introducing the same nitrogen load as dietary protein.
That mechanism explains why ketoanalogues are generally discussed together with carefully controlled low- or very-low-protein diets rather than as independent kidney-protective pills.
Nefrogard should not be described as a tablet that simply “cleans,” repairs, or strengthens the kidneys. Its clinical rationale is more specific: ketoanalogues can help support amino-acid and protein nutrition when protein intake is deliberately restricted in selected people with CKD.
How Does Nefrogard Tablet Support People With CKD?
Nefrogard is intended to complement protein restriction by supplying ketoanalogues and amino acids while helping limit nitrogen intake. This can be useful because breaking down dietary protein produces nitrogen-containing waste that impaired kidneys have greater difficulty eliminating.
Ketoacid analogues can be converted to amino acids after accepting nitrogen groups already present in the body. KDIGO explains that, because these analogues lack an amino group, they can serve as substrates for protein synthesis without generating the same additional nitrogenous waste.
Why does nitrogen matter in kidney disease?
Healthy kidneys remove many waste products generated through normal metabolism. When kidney function declines substantially, nitrogen-containing compounds such as urea can accumulate.
Reducing protein intake can decrease the production of some of these wastes, but excessive protein restriction can create nutritional problems. Ketoanalogue-supplemented diets attempt to balance these competing concerns.
This is why adequate energy intake and professional nutritional supervision are important. Centaur's prescribing information specifically advises ensuring sufficient calorie intake during treatment.
Can Nefrogard reduce urea?
Ketoanalogue-supplemented protein-restricted diets can reduce nitrogenous waste production, and lowering blood urea nitrogen has been observed in clinical research. However, this effect should be attributed to the combined dietary strategy rather than assuming that Nefrogard alone lowers urea regardless of diet.
A falling urea level also does not by itself prove that CKD has improved. Kidney function needs to be assessed using appropriate clinical and laboratory measures.
What Are the Potential Benefits of Nefrogard Tablet?
The potential benefits relate mainly to supporting a prescribed protein-restricted diet while attempting to reduce metabolic burden in CKD. Evidence for ketoanalogue-supplemented diets suggests possible benefits in selected patients, but studies have not produced uniformly consistent results.
Potential benefits of Nefrogard and the strength of the supporting rationale
Potential role | What it means | Evidence perspective |
Support during protein restriction | Supplies ketoanalogues/amino acids while dietary protein is restricted | Established nutritional rationale |
Limit additional nitrogen load | Ketoanalogues lack the amino group found in amino acids | Established mechanism |
Reduce uremic waste production | Protein restriction plus ketoanalogues may reduce nitrogenous waste | Supported, but dependent on the overall diet |
Help maintain nutrition | May help provide essential amino-acid substrates during carefully controlled protein restriction | Requires adequate calories and monitoring |
Slow CKD progression | Some trials and reviews suggest benefit in selected patients | Evidence remains mixed and patient selection matters |
Delay kidney replacement therapy | Reported in some studies of supervised very-low-protein diets plus ketoanalogues | Not guaranteed; other studies have not reproduced all benefits |
Cure CKD | Restore permanently damaged kidney tissue | Not supported |
The distinction in the final rows is important. KDIGO 2024 notes that one controlled study of a supplemented vegetarian very-low-protein diet slowed eGFR decline and reduced the need for kidney replacement therapy, while a subsequent pragmatic trial did not reproduce the finding.
Can ketoanalogues slow chronic kidney disease?
Possibly in carefully selected patients, but the magnitude and consistency of benefit remain uncertain.
A 2024 systematic review and meta-analysis evaluated randomized trials of ketoanalogue supplementation combined with protein-restricted diets in stage 3–5 CKD. The authors explicitly noted continuing uncertainty regarding the balance of benefits and harms, illustrating why this approach should not be marketed as proven kidney regeneration.
Earlier systematic research has found favorable effects on measures such as eGFR, proteinuria, phosphorus and some metabolic parameters, although study designs, diets and populations differ.
Why Is Nefrogard Usually Paired With a Low-Protein Diet?
The dietary component is central to the treatment strategy. Taking ketoanalogues while continuing an unrestricted high-protein diet does not reproduce the therapeutic approach studied in CKD nutrition trials.
The KDIGO 2024 CKD guideline on dietary protein generally suggests maintaining protein intake around 0.8 g/kg body weight per day in adults with CKD stages G3–G5 and avoiding high protein intake above 1.3 g/kg/day in adults at risk of progression.
For adults with CKD who are willing and able and are at risk of kidney failure, KDIGO says clinicians may consider, under close supervision, a very-low-protein diet supplemented with essential amino acids or ketoacid analogues.
Should everyone with CKD eat a very-low-protein diet?
No. Protein restriction must be individualized.
KDIGO specifically advises against low- or very-low-protein diets in metabolically unstable people with CKD. It also highlights special considerations for older adults with frailty or sarcopenia, in whom higher protein and calorie targets may sometimes be appropriate.
Trying to create a very-low-protein diet without a renal dietitian or nephrology team can increase the risk of inadequate nutrition, muscle loss and poor calorie intake.
What about people with diabetes and CKD?
Dietary decisions can differ when diabetes is present.
The 2020 KDOQI nutrition guideline described a protein range of 0.6–0.8 g/kg/day for adults with CKD stages 3–5 and diabetes under close supervision, whereas its ketoanalogue-supplemented very-low-protein recommendation focused on metabolically stable adults without diabetes.
More recent Asia-Pacific diabetic kidney disease guidance also describes evidence for ketoanalogues as not robust, noting variable results and limitations in studies examining harder CKD outcomes.
This is another reason Nefrogard should not be self-prescribed simply because someone has an abnormal creatinine result.
How Is Nefrogard Different From an Ordinary Kidney Supplement?
Nefrogard has a specific nutritional purpose within CKD management. It should not be grouped with herbal “kidney detox” products or general multivitamins.
Current Indian product information identifies the standard Nefrogard Tablet as an alpha-ketoanalogue product from Centaur Pharmaceuticals.
The formulation listed by Indian pharmacy information includes calcium salts of ketoanalogues corresponding to essential amino acids together with amino acids such as lysine, threonine, tryptophan, histidine and tyrosine.
Nefrogard versus common “kidney support” concepts
Product or approach | Main purpose | Important point |
Nefrogard / ketoanalogue therapy | Support carefully controlled protein restriction in selected CKD patients | Should be integrated with medical nutrition therapy |
Standard multivitamin | Correct or prevent specific nutrient deficiencies | Does not substitute for CKD treatment |
Varies widely by product | Effectiveness and kidney safety may be uncertain | |
Increase protein intake | May conflict with a prescribed protein-restricted CKD diet | |
Evidence-based CKD medication | Treat specific mechanisms contributing to CKD progression | Selected according to diagnosis, kidney function and comorbidities |
Renal dietitian-guided nutrition | Individualize protein, sodium, potassium, phosphorus and energy intake | Core part of comprehensive CKD care |
Nefrogard also should not be confused with Nefrogard DS simply because the brand names are similar.
Current listings describe them separately, so patients should check the exact formulation written on their prescription and packaging.
What Are the Side Effects and Precautions With Nefrogard?
Calcium monitoring is particularly important because Nefrogard contains calcium salts and hypercalcaemia—an abnormally high blood calcium level—is a recognized concern.
Centaur's prescribing information lists hypercalcaemia, hypersensitivity to ingredients, and disturbed amino-acid metabolism among contraindications. It recommends regular monitoring of serum calcium.
Which medicines can interact with Nefrogard?
Calcium-containing products can increase the risk of elevated blood calcium. The calcium in Nefrogard can also interfere with absorption of medicines or supplements that form poorly soluble compounds with calcium.
The manufacturer's information specifically mentions tetracycline antibiotics, quinolones such as ciprofloxacin and norfloxacin, and products containing iron, fluoride or estramustine. It recommends separating these from Nefrogard rather than taking them simultaneously.
Do not change prescription timing independently; a doctor or pharmacist can determine an appropriate schedule for the specific medicines involved.
Who needs particular medical supervision?
Anyone with CKD taking Nefrogard should already be under appropriate clinical supervision. Extra consideration is warranted with high blood calcium, unusual amino-acid metabolism, phenylketonuria, pregnancy or breastfeeding, liver disease, multiple medicines, or substantial nutritional problems.
The manufacturer's information notes that Nefrogard contains phenylalanine, which matters in hereditary phenylketonuria. It also reports insufficient safety information for pregnancy, breastfeeding and pediatric use.
When Should You Contact Your Kidney Specialist?
Nefrogard should be part of a monitored CKD plan rather than used to self-treat abnormal creatinine, swelling or urinary symptoms. Kidney disease management depends on the cause and stage of CKD, urine albumin, blood pressure, diabetes status, medications, electrolyte balance and nutritional health.
Contact your healthcare team if you develop persistent nausea or vomiting, worsening loss of appetite, increasing weakness, significant swelling, breathlessness, markedly reduced urine output, confusion, or other substantial changes while living with CKD. Severe breathlessness, chest symptoms, confusion or rapidly worsening illness can require urgent medical assessment.
Laboratory monitoring may include kidney function and relevant electrolytes and minerals. Nefrogard's manufacturer specifically recommends serum-calcium monitoring, with additional phosphate monitoring in certain treatment combinations.
Do not independently reduce dietary protein to very low levels simply because you have started a ketoanalogue product. KDIGO emphasizes close supervision for supplemented very-low-protein diets because nutritional stability and adequate energy intake are essential.
Conclusion
Nefrogard Tablet is a specialized alpha-ketoanalogue preparation used alongside protein-restricted nutrition in selected people with chronic kidney disease. Its purpose is to help provide essential amino-acid substrates while limiting additional nitrogen load, not to detoxify, regenerate or cure damaged kidneys. Clinical guidelines recognize ketoanalogue-supplemented very-low-protein diets as an option for carefully selected, metabolically stable adults under close supervision, although evidence for delaying CKD progression is not uniformly conclusive.
Because nutritional requirements differ by CKD stage, diabetes status, age and nutritional health, Nefrogard and protein restriction should be planned with a nephrologist and renal dietitian. Calcium levels, kidney function and overall nutritional status may also require monitoring.
Frequently Asked Questions
1. What is Nefrogard Tablet used for?
Nefrogard is used as nutritional therapy in selected people with chronic kidney disease, usually alongside a prescribed protein-restricted diet. It contains ketoanalogues and amino acids intended to support protein nutrition while limiting additional nitrogenous waste.
2. Does Nefrogard lower creatinine?
Nefrogard should not be described as a creatinine-lowering medicine. Ketoanalogue-supplemented protein restriction has been studied for effects on CKD progression and kidney-function measures, but results are not completely consistent. Treatment success should be assessed using the broader clinical picture rather than one creatinine result.
3. Can Nefrogard prevent dialysis?
Some studies of supervised ketoanalogue-supplemented very-low-protein diets have reported delayed kidney replacement therapy, but this outcome is not guaranteed. KDIGO notes that positive findings from one important trial were not reproduced in a later pragmatic study.
4. Should Nefrogard be taken with a low-protein diet?
Its clinical rationale is closely linked to protein restriction. Current KDIGO guidance allows consideration of ketoacid analogue-supplemented very-low-protein diets for selected adults at risk of kidney failure, but only under close supervision. Do not start severe protein restriction without professional nutritional planning.
5. Can Nefrogard cause high calcium?
Yes, elevated blood calcium is an important potential concern because the formulation contains calcium salts. The manufacturer's prescribing information lists hypercalcaemia as a contraindication and recommends regular serum-calcium monitoring. Other calcium-containing products should therefore be discussed with the treating clinician.
6. Is Nefrogard safe to take without a doctor's prescription?
It should not be self-started as a general kidney supplement. Appropriate use depends on CKD stage, nutritional status, protein intake, calcium levels and other medicines. A nephrologist and renal dietitian can determine whether ketoanalogue-supported protein restriction is suitable for an individual patient.
Comments